-74%

est. 2Y upside i

HealthcareSeries C

Rank

#4068

Sector

Healthcare Technology

Est. Liquidity

~3Y

Data Quality

Data: Medium

Solv Health presents a risky equity opportunity for a job seeker.

Last updated: March 10, 2026

Bull (10%)+150%

Solv successfully expands its national network, deepens EHR integrations, and fends off competitive threats by leveraging its hybrid revenue model and strong patient engagement. This drives revenue to over $50M by 2028, justifying a $1B+ valuation at IPO, a 2.5x increase from current levels.

Base (35%)+25%

Solv continues to grow its provider network and patient base, but faces persistent competition from Zocdoc and incumbent EHR systems. Revenue grows steadily to ~$20M by 2028, leading to an acquisition or modest IPO at a $500M valuation, a 1.25x return.

Bear (55%)-60%

Increased competitive pressure from dominant incumbents like Epic and Teladoc, coupled with negative impacts from the ongoing lawsuit and data breach concerns, significantly hinder growth and market perception. Revenue growth stalls, leading to a down round or acquisition at a $160M valuation, wiping out most common stock value given the preference stack.

Est. time to liquidity~3.0 years

Preference Stack Risk

high

Funding Intensity

24%

Investors hold $95M in liquidation preferences ahead of common stock, meaning common shareholders would only see returns after this amount is paid out in an exit.

Dilution Risk

high

Given the time since the Series C round (2021), further funding rounds are likely before an IPO, which would lead to additional dilution for existing equity holders.

Secondary Liquidity

limited

While pre-IPO investment opportunities exist for accredited investors, there is no indication of an active secondary market for employee equity.

View all 6 open roles at solv →

Last updated: February 18, 2026

Questions to Ask at the Interview

Strategic questions based on solv's data — designed to show you've done your homework.

  • 1

    “Given the federal lawsuit filed by urgent care operators in October 2025, how is Solv Health addressing these allegations and what measures are being taken to rebuild trust with providers and ensure compliance?”

  • 2

    “With a current revenue of ~$6M and a $400M valuation, what is the company's specific growth strategy to justify this high multiple, particularly in light of strong competition from Zocdoc and the potential for EHR giants like Epic to expand their patient-facing features?”

  • 3

    “Considering the Series C round was in 2021 and the 'high' preference stack, what is the anticipated timeline and strategy for a liquidity event (IPO or acquisition), and how is the company planning to manage potential further dilution for employees holding common stock or options?”

Community

Valuation Sentiment

Our model estimates -74% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.